The clinical usefulness of knowing CHRNA5 polymorphism genotype: paving the way for personalized therapy
Tobacco smoking is a leading cause of global mortality, with cessation being the primary prevention strategy. Nicotine addiction has a genetic component; the rs503464 single nucleotide polymorphism (SNP) in the CHRNA5 gene is associated with smoking cessation therapy success.